Frontiers in Hematology

Case Report

Published on 06 Mar 2024

Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation

in Red Cells, Iron and Erythropoiesis

Tiziana Coppola
Hannah Hughes
Paul T. Finch
Joshua A. Hess
Steve Wu
Carlos E. Prada
Alexander G. Miethke
Wenying Zhang
Theodosia A. Kalfa

Frontiers in Hematology

doi 10.3389/frhem.2024.1331485

901 views
1 citation

Case Report

Published on 06 Mar 2024

Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib

in Blood Cancer

Dan Liu
Lijie Xing
Hui Wang
Ping Li
Haichen Wei

Frontiers in Hematology

doi 10.3389/frhem.2024.1334577

979 views
1 citation

Review

Published on 01 Mar 2024

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche

in Hematopoiesis and Stem Cells

Steven Ngo
Despoina Papazoglou
Hector Huerga Encabo
Dominique Bonnet

Frontiers in Hematology

doi 10.3389/frhem.2024.1334807

1,721 views
1 citation

Review

Published on 19 Feb 2024

Hypersialylation and multiple myeloma

in Blood Cancer

Michael O’Dwyer
Siobhan Glavey
Roisin McAvera
Alessandro Natoni
Aideen E. Ryan

Frontiers in Hematology

doi 10.3389/frhem.2024.1360149

3,813 views
1 citation

Review

Published on 15 Feb 2024

Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer

in Blood Cancer

Guillermo Garcia-Manero
Uwe Platzbecker
Kian-Huat Lim
Grzegorz Nowakowski
Omar Abdel-Wahab
Hagop Kantarjian
Amit Verma
Daniel T. Starczynowski

Frontiers in Hematology

doi 10.3389/frhem.2024.1339870

4,247 views
5 citations

Original Research

Published on 05 Feb 2024

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

in Red Cells, Iron and Erythropoiesis

Kunapa Iam-arunthai
Tawatchai Suwanban
Pravinwan Thungthong
Supat Chamnanchanunt
Suthat Fucharoen

Frontiers in Hematology

doi 10.3389/frhem.2024.1339026

3,393 views

Review

Published on 02 Feb 2024

How artificial intelligence revolutionizes the world of multiple myeloma

in Blood Cancer

Martha Romero
Adrián Mosquera Orgueira
Mateo Mejía Saldarriaga

Frontiers in Hematology

doi 10.3389/frhem.2024.1331109

3,107 views
3 citations

Review

Published on 25 Jan 2024

De novo drug design through artificial intelligence: an introduction

in Blood Cancer

Davide Crucitti
Carlos Pérez Míguez
José Ángel Díaz Arias
Diego Beltrán Fernandez Prada
Adrián Mosquera Orgueira

Frontiers in Hematology

doi 10.3389/frhem.2024.1305741

6,739 views
7 citations

Brief Research Report

Published on 25 Jan 2024

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia

in Blood Cancer

Tao Zhang
Glenn Marsman
Diego A. Pereira-Martins
Manfred Wuhrer
Gerwin A. Huls
Valerie R. Wiersma

Frontiers in Hematology

doi 10.3389/frhem.2023.1302328

1,326 views
1 citation

Original Research

Published on 19 Jan 2024

Generation, characterization, and use of EKLF(Klf1)/CRE knock-in mice for cell-restricted analyses

in Red Cells, Iron and Erythropoiesis

Li Xue
Kaustav Mukherjee
Kevin A. Kelley
James J. Bieker

Frontiers in Hematology

doi 10.3389/frhem.2023.1292589

1,094 views

Mini Review

Published on 11 Jan 2024

Mini review of metabolism in leukaemia: from complexity to the clinic

in Hematopoiesis and Stem Cells

Kevin M. Rattigan

Frontiers in Hematology

doi 10.3389/frhem.2023.1353994

800 views

Case Report

Published on 09 Jan 2024

Persistent hypersplenism following successful hematopoietic stem cell transplantation: unraveling the cellular components of extramedullary residual disease and donor hematopoiesis—a case report

in Hematopoiesis and Stem Cells

Eleni Besiridou
Osheen Bhatt
Andrea Yurukova
Anshupa Sahu
Sarah Kinkley
Victoria Fischer
Ioanna Triviai

Frontiers in Hematology

doi 10.3389/frhem.2023.1328503

1,230 views

Original Research

Published on 08 Jan 2024

Vhl deletion in Dmp1-expressing cells alters MEP metabolism and promotes stress erythropoiesis

in Red Cells, Iron and Erythropoiesis

Janna M. Emery
Betsabel Chicana
Hanna Taglinao
Citlaly Ponce
Cristine Donham
Hawa Padmore
Aimy Sebastian
Scott L. Trasti
Jennifer O. Manilay

Frontiers in Hematology

doi 10.3389/frhem.2023.1276426

1,186 views

Review

Published on 19 Dec 2023

R-loops in normal and malignant hematopoiesis

in Hematopoiesis and Stem Cells

Mayumi Hirayama
Satoru Shinriki
Hirotaka Matsui

Frontiers in Hematology

doi 10.3389/frhem.2023.1297657

1,512 views
1 citation

Mini Review

Published on 04 Dec 2023

Bcl-2 inhibition in the treatment of hematologic malignancies

in Blood Cancer

John X. Wei
Marina Konopleva

Frontiers in Hematology

doi 10.3389/frhem.2023.1307661

1,394 views
1 citation

Mini Review

Published on 28 Nov 2023

Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology

in Blood Cancer

Candela Ceballos
Mª Cruz Viguria
Carlos Panizo
Juan Roberto Rodríguez-Madoz
Felipe Prósper

Frontiers in Hematology

doi 10.3389/frhem.2023.1217775

1,493 views

Navigation group

Articles

Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation

Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche

Hypersialylation and multiple myeloma

Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

How artificial intelligence revolutionizes the world of multiple myeloma

De novo drug design through artificial intelligence: an introduction

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia

Generation, characterization, and use of EKLF(Klf1)/CRE knock-in mice for cell-restricted analyses

Mini review of metabolism in leukaemia: from complexity to the clinic

Persistent hypersplenism following successful hematopoietic stem cell transplantation: unraveling the cellular components of extramedullary residual disease and donor hematopoiesis—a case report

Vhl deletion in Dmp1-expressing cells alters MEP metabolism and promotes stress erythropoiesis

R-loops in normal and malignant hematopoiesis

Bcl-2 inhibition in the treatment of hematologic malignancies

Mini review: Advances and challenges in CAR-T cell therapy: from early chimeric antigen receptors to future frontiers in oncology